𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer

✍ Scribed by John A. Tayek; David Heber; Lauri O. Byerley; Barbara Steiner; Jacob Rajfer; Ronald S. Swerdloff

Book ID
116030149
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
737 KB
Volume
39
Category
Article
ISSN
1532-8600

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metabolic changes during gonadotropin-re
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer : Differences from the classic metabolic syndrome
✍ Matthew R. Smith; Hang Lee; Francis McGovern; Mary Anne Fallon; Melissa Goode; A πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## BACKGROUND. In men with prostate cancer, gonadotropin‐releasing hormone (GnRH) agonists increase fat mass, decrease insulin sensitivity, and increase triglycerides, features that are shared with metabolic syndrome. To the authors' knowledge, however, less is known regarding the effe